Related Experiment Videos

Symptomatic uses of caffeine in patients with cancer

Paolo L Manfredi¹, Gilbert R Gonzales

¹Pain and Palliative Care Service, Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Journal of Palliative Care

|April 25, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants.

International clinical psychopharmacology·2026

Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N-Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure.

Journal of medicinal chemistry·2026

Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.

Pharmacological research·2025

Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis: An Exploratory Post Hoc Analysis From a Phase 3 Randomized Controlled Trial.

The Journal of clinical psychiatry·2025

Evidence of osteoarthritis disease modification with a Sn-117m microparticle device: a review and validation in mammalian models.

Frontiers in veterinary science·2025

A novel artificial intelligence-based methodology to predict non-specific response to treatment.

Psychiatry research·2025

See all related articles